{"name": "Aton Pharma",
 "permalink": "aton-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/aton-pharma",
 "homepage_url": "http://www.atonrx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2001,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "609-671-9010",
 "description": "",
 "created_at": "Thu May 06 03:00:57 UTC 2010",
 "updated_at": "Thu May 06 03:00:57 UTC 2010",
 "overview": "\u003Cp\u003EAton Pharma, Inc. operates as a specialty pharmaceutical company. It focuses on ophthalmic diseases, orphan conditions, and acute care hospital products. The company offers products for metabolic, neurological, and cardiovascular diseases, as well as provides products for under-treated diseases, including dry eye. Its products include timolol maleate ophthalmic gel forming solution for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The company serves patients, caregivers, and healthcare professionals in the United States, the Asia Pacific region, Australia, and internationally. Aton Pharma, Inc. was formerly known as Avatar. The company was founded in 2001 and is based in Lawrenceville, New Jersey. Aton Pharma, Inc. is a former subsidiary of Merck \u0026amp; Co., Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       82],
      "assets/images/resized/0008/6165/86165v1-max-150x150.jpg"],
     [[194,
       107],
      "assets/images/resized/0008/6165/86165v1-max-250x250.jpg"],
     [[194,
       107],
      "assets/images/resized/0008/6165/86165v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO, Founder",
    "person":
     {"first_name": "Michael",
      "last_name": "G. Wells",
      "permalink": "michael-g-wells",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "George",
      "last_name": "J. Parise",
      "permalink": "george-j-parise",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 318000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.fiercebiotech.com/story/valeant-buy-orphan-drug-developer-aton-318m/2010-05-03?utm_medium=rss\u0026utm_source=rss",
   "source_description": "Valeant to buy orphan drug developer Aton for $318M",
   "acquired_year": 2010,
   "acquired_month": 5,
   "acquired_day": 3,
   "acquiring_company":
    {"name": "Valeant Pharmaceuticals International",
     "permalink": "valeant-pharmaceuticals-international",
     "image":
      {"available_sizes":
        [[[150,
           28],
          "assets/images/resized/0006/1320/61320v1-max-150x150.png"],
         [[250,
           47],
          "assets/images/resized/0006/1320/61320v1-max-250x250.png"],
         [[255,
           48],
          "assets/images/resized/0006/1320/61320v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3150 Brunswick Pike",
    "address2": "Suite 230",
    "zip_code": "08648",
    "city": "Lawrenceville",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0008/6164/86164v1-max-150x150.jpg"],
      [[250,
        132],
       "assets/images/resized/0008/6164/86164v1-max-250x250.jpg"],
      [[450,
        238],
       "assets/images/resized/0008/6164/86164v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}